Khemraj Hirani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Khemraj Hirani has a total of 119 co-authors. Here are the top co-authors by number of shared publications:
- Rahul Mittal
Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL 33136, USA
28 shared publications Joana R. N. Lemos
Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL, United States
10 shared publicationsMannat Mittal
Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL, USA
8 shared publications- Joana R. N. Lemos
Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL, USA
7 shared publications Danay Saavedra
Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL, USA
3 shared publicationsGrant Keith
School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA
3 shared publications
Latest Publications
- Open Access
- 2 October 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (40)
Positivity bias in scientific research: Solutions for change
Procedural and cultural reforms can mitigate the effects of positivity bias and further strengthen research integrity and public trust.
- 2 October 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (40)
Open AccessPositivity bias in scientific research: Solutions for change
Procedural and cultural reforms can mitigate the effects of positivity bias and further strengthen research integrity and public trust.
- Open Access
- 25 September 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (39)
The hidden cost of positivity: Ensuring integrity in scientific research
Positivity bias skews the scientific record by favoring positive results. Understanding the drivers and impact of such bias provides a foundation for creating solutions.
- 25 September 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (39)
Open AccessThe hidden cost of positivity: Ensuring integrity in scientific research
Positivity bias skews the scientific record by favoring positive results. Understanding the drivers and impact of such bias provides a foundation for creating solutions.
- Open Access
- 21 August 2026
- Published by MDPI AG in Antioxidants
- Vol. 15 (8) , 1044
Oxidative Stress Biomarkers in Pediatric and Early-Stage Type 1 Diabetes: Toward Redox Phenotyping
Type 1 diabetes (T1D) is characterized by autoimmune β-cell destruction, metabolic instability, and long-term susceptibility to vascular and renal complications. Oxidative stress has been widely implicated in these processes, but it is often described as a generalized consequence of hyperglycemia, not as a measurable and heterogeneous biological state. In this review, we propose exploratory redox phenotyping as a framework for characterizing oxidative stress in pediatric and early-stage T1D. This approach integrates biomarkers of antioxidant defense, lipid peroxidation, protein oxidation, DNA oxidation, and inflammation-associated redox activity to explore potentially distinct patterns of redox dysregulation. Key biomarker domains include enzymatic antioxidant systems, lipid-peroxidation products, protein- and DNA-oxidation markers, and inflammatory mediators, which may collectively characterize the intensity, molecular compartment, and possible clinical relevance of redox dysregulation. Across pediatric presymptomatic T1D, newly diagnosed disease, partial remission, and short-duration established T1D, longitudinal redox profiling may help distinguish stage-specific or transient metabolic responses from persistent oxidative dysregulation. These clinical phases are considered separately as they differ in immune activity, residual C-peptide secretion, glycemic exposure, and biological susceptibility. Redox phenotyping may also improve the design of antioxidant, mitochondrial, anti-inflammatory, and NRF2-targeted interventions by enabling biomarker-based patient selection. By defining oxidative stress as a stratifiable biological domain, this framework may advance precision risk assessment and guide more rational, targeted redox-directed therapies for children and individuals with early-stage T1D. At present, these proposed profiles remain hypothetical and require validation in prospective cohorts using standardized assays, reproducible thresholds, and clinically meaningful outcomes.
- 21 August 2026
- Published by MDPI AG in Antioxidants
- Vol. 15 (8) , 1044
Open AccessOxidative Stress Biomarkers in Pediatric and Early-Stage Type 1 Diabetes: Toward Redox Phenotyping
Type 1 diabetes (T1D) is characterized by autoimmune β-cell destruction, metabolic instability, and long-term susceptibility to vascular and renal complications. Oxidative stress has been widely implicated in these processes, but it is often described as a generalized consequence of hyperglycemia, not as a measurable and heterogeneous biological state. In this review, we propose exploratory redox phenotyping as a framework for characterizing oxidative stress in pediatric and early-stage T1D. This approach integrates biomarkers of antioxidant defense, lipid peroxidation, protein oxidation, DNA oxidation, and inflammation-associated redox activity to explore potentially distinct patterns of redox dysregulation. Key biomarker domains include enzymatic antioxidant systems, lipid-peroxidation products, protein- and DNA-oxidation markers, and inflammatory mediators, which may collectively characterize the intensity, molecular compartment, and possible clinical relevance of redox dysregulation. Across pediatric presymptomatic T1D, newly diagnosed disease, partial remission, and short-duration established T1D, longitudinal redox profiling may help distinguish stage-specific or transient metabolic responses from persistent oxidative dysregulation. These clinical phases are considered separately as they differ in immune activity, residual C-peptide secretion, glycemic exposure, and biological susceptibility. Redox phenotyping may also improve the design of antioxidant, mitochondrial, anti-inflammatory, and NRF2-targeted interventions by enabling biomarker-based patient selection. By defining oxidative stress as a stratifiable biological domain, this framework may advance precision risk assessment and guide more rational, targeted redox-directed therapies for children and individuals with early-stage T1D. At present, these proposed profiles remain hypothetical and require validation in prospective cohorts using standardized assays, reproducible thresholds, and clinically meaningful outcomes.
- Open Access
- 30 July 2026
- Published by Wolters Kluwer Health in Aging Advances
- Vol. 3 (4) , 180-197
Molecular and epigenetic landscapes of immunosenescence in biological aging: A narrative review
Aging is increasingly recognized as a heterogeneous biological process rather than a uniform chronological phenomenon. Immunosenescence has emerged as a central hallmark of biological aging, profoundly shaping susceptibility to infection, malignancy, autoimmunity, and poor vaccine responses. This progressive decline encompasses both innate and adaptive immunity and is marked by impaired antigen presentation, thymic involution, reduced lymphopoiesis, repertoire contraction, and the establishment of chronic low-grade inflammation. Importantly, immunosenescence does not occur solely as a consequence of chronological time but is accelerated by chronic conditions such as human immunodeficiency virus (HIV) infection, autoimmune disease, metabolic syndrome, chronic kidney disease, and cancer therapy, underscoring the dissociation between chronological and biological immune age. At the molecular level, aged lymphocytes accumulate DNA damage, mitochondrial dysfunction, and metabolic stress that drive canonical senescence pathways. Classical markers, including p16 inhibitor of cyclin-dependent kinase 4a (p16INK4a), p21 cyclin-dependent kinase–interacting protein 1 (p21CIP1), gamma-H2A histone family member X (γH2AX), and senescence-associated β-galactosidase (SA-β-gal), are now complemented by novel signatures such as immune-specific DNA methylation clocks, histone modifications, noncoding RNA networks, telomeric repeat-containing RNAs, mitochondrial dysfunction metrics, and profiles of the senescence-associated secretory phenotype. These biomarkers provide quantitative measures of immune biological age that surpass chronological metrics in predicting health outcomes. This review synthesizes emerging molecular and epigenetic frameworks that redefine immunosenescence as a quantifiable and disease-modifiable dimension of biological aging rather than a passive consequence of chronological time. By integrating immune-specific epigenetic clocks, mitochondrial and telomeric stress signatures, and senescence-associated secretory phenotypes, we highlight actionable biomarkers that enable precise stratification of immune biological age. These insights provide a translational roadmap for targeting immune aging through senotherapeutics, metabolic and epigenetic interventions, and optimized vaccine strategies, advancing immunosenescence toward precision geromedicine. Future advances will arise from longitudinal studies employing single-cell multi-omics, repertoire sequencing, and artificial intelligence–driven modeling to refine predictive aging clocks. Translational strategies targeting immune aging, including senolytics, senomorphics, metabolic modulators, epigenetic reprogramming, and next-generation vaccine adjuvants, hold promise for restoring immune resilience. Integrating these insights into precision medicine frameworks may transform immunosenescence from an inevitable feature of aging into a modifiable determinant of healthspan.
- 30 July 2026
- Published by Wolters Kluwer Health in Aging Advances
- Vol. 3 (4) , 180-197
Open AccessMolecular and epigenetic landscapes of immunosenescence in biological aging: A narrative review
Aging is increasingly recognized as a heterogeneous biological process rather than a uniform chronological phenomenon. Immunosenescence has emerged as a central hallmark of biological aging, profoundly shaping susceptibility to infection, malignancy, autoimmunity, and poor vaccine responses. This progressive decline encompasses both innate and adaptive immunity and is marked by impaired antigen presentation, thymic involution, reduced lymphopoiesis, repertoire contraction, and the establishment of chronic low-grade inflammation. Importantly, immunosenescence does not occur solely as a consequence of chronological time but is accelerated by chronic conditions such as human immunodeficiency virus (HIV) infection, autoimmune disease, metabolic syndrome, chronic kidney disease, and cancer therapy, underscoring the dissociation between chronological and biological immune age. At the molecular level, aged lymphocytes accumulate DNA damage, mitochondrial dysfunction, and metabolic stress that drive canonical senescence pathways. Classical markers, including p16 inhibitor of cyclin-dependent kinase 4a (p16INK4a), p21 cyclin-dependent kinase–interacting protein 1 (p21CIP1), gamma-H2A histone family member X (γH2AX), and senescence-associated β-galactosidase (SA-β-gal), are now complemented by novel signatures such as immune-specific DNA methylation clocks, histone modifications, noncoding RNA networks, telomeric repeat-containing RNAs, mitochondrial dysfunction metrics, and profiles of the senescence-associated secretory phenotype. These biomarkers provide quantitative measures of immune biological age that surpass chronological metrics in predicting health outcomes. This review synthesizes emerging molecular and epigenetic frameworks that redefine immunosenescence as a quantifiable and disease-modifiable dimension of biological aging rather than a passive consequence of chronological time. By integrating immune-specific epigenetic clocks, mitochondrial and telomeric stress signatures, and senescence-associated secretory phenotypes, we highlight actionable biomarkers that enable precise stratification of immune biological age. These insights provide a translational roadmap for targeting immune aging through senotherapeutics, metabolic and epigenetic interventions, and optimized vaccine strategies, advancing immunosenescence toward precision geromedicine. Future advances will arise from longitudinal studies employing single-cell multi-omics, repertoire sequencing, and artificial intelligence–driven modeling to refine predictive aging clocks. Translational strategies targeting immune aging, including senolytics, senomorphics, metabolic modulators, epigenetic reprogramming, and next-generation vaccine adjuvants, hold promise for restoring immune resilience. Integrating these insights into precision medicine frameworks may transform immunosenescence from an inevitable feature of aging into a modifiable determinant of healthspan.
- Open Access
- 23 July 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (15) , 6556
Structural Remodeling of TCR–HLA-DQ8 Recognition by a β-Cell Stress-Associated C19S Insulin Neoepitope in Type 1 Diabetes
Inflammatory and oxidative stress within the pancreatic islet microenvironment can alter insulin-derived peptides and generate neoepitopes that may reshape autoreactive T cell recognition in type 1 diabetes (T1D). One such modification, C19S, represents a cysteine-to-serine substitution at position 19 of the insulin B-chain and has recently been identified among human leukocyte antigen class II (HLA-II)-associated insulin neoepitopes recognized by autoreactive CD4+ T cells. Although the biological relevance of C19S has been determined, the molecular features that may distinguish C19S-specific T cell receptor (TCR) engagement from native insulin recognition remain incompletely defined. Here, we used comparative protein–protein docking, molecular dynamics (MD) simulations, interface-contact analysis, conformational landscape analysis, and binding-energy calculations to examine TCR engagement of human leukocyte antigen DQ8 (HLA-DQ8) presenting either native insulin peptide or the corresponding C19S insulin peptide. Initial modeling indicated that both peptide-HLA-DQ8 complexes were compatible with TCR-bound ternary complex formation. However, the C19S-containing complex was predicted to exhibit altered peptide-centered dynamics, changes in peptide backbone presentation, and reorganization of both TCR-peptide and TCR-HLA-DQ8 contacts. Comparative molecular mechanics Poisson–Boltzmann surface area (MM/PBSA) and molecular mechanics generalized Born surface area (MM/GBSA) analyses further suggested a distinct calculated energetic profile under the applied modeling conditions for the C19S-containing complex, with residue-level decomposition localizing energetic differences to selected interface hotspots. Together, these findings provide a molecular framework for generating hypotheses about how C19S may reshape the HLA-DQ8-presented insulin recognition surface, with implications for future experimental studies of autoreactive CD4+ T cell recognition and antigen-specific tolerogenic strategies in T1D.
- 23 July 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (15) , 6556
Open AccessStructural Remodeling of TCR–HLA-DQ8 Recognition by a β-Cell Stress-Associated C19S Insulin Neoepitope in Type 1 Diabetes
Inflammatory and oxidative stress within the pancreatic islet microenvironment can alter insulin-derived peptides and generate neoepitopes that may reshape autoreactive T cell recognition in type 1 diabetes (T1D). One such modification, C19S, represents a cysteine-to-serine substitution at position 19 of the insulin B-chain and has recently been identified among human leukocyte antigen class II (HLA-II)-associated insulin neoepitopes recognized by autoreactive CD4+ T cells. Although the biological relevance of C19S has been determined, the molecular features that may distinguish C19S-specific T cell receptor (TCR) engagement from native insulin recognition remain incompletely defined. Here, we used comparative protein–protein docking, molecular dynamics (MD) simulations, interface-contact analysis, conformational landscape analysis, and binding-energy calculations to examine TCR engagement of human leukocyte antigen DQ8 (HLA-DQ8) presenting either native insulin peptide or the corresponding C19S insulin peptide. Initial modeling indicated that both peptide-HLA-DQ8 complexes were compatible with TCR-bound ternary complex formation. However, the C19S-containing complex was predicted to exhibit altered peptide-centered dynamics, changes in peptide backbone presentation, and reorganization of both TCR-peptide and TCR-HLA-DQ8 contacts. Comparative molecular mechanics Poisson–Boltzmann surface area (MM/PBSA) and molecular mechanics generalized Born surface area (MM/GBSA) analyses further suggested a distinct calculated energetic profile under the applied modeling conditions for the C19S-containing complex, with residue-level decomposition localizing energetic differences to selected interface hotspots. Together, these findings provide a molecular framework for generating hypotheses about how C19S may reshape the HLA-DQ8-presented insulin recognition surface, with implications for future experimental studies of autoreactive CD4+ T cell recognition and antigen-specific tolerogenic strategies in T1D.
- Open Access
- 12 June 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1831391
Immune signaling as a determinant of cellular identity and tissue function
Immunology has traditionally interpreted tissue pathology through models centered on immune-mediated cytotoxicity. In this prevailing model, functional decline is considered a downstream consequence of cell death and irreversible loss of cellular mass. Increasing evidence across metabolically active tissues challenges this paradigm by demonstrating that immune-derived signals exert potent regulatory effects on cellular identity that are independent of overt cytotoxicity. Cytokines, interferons, and inflammatory mediators directly engage transcriptional, epigenetic, and stress-response networks that sustain differentiated states. This engagement leads to suppression of lineage-defining gene programs, destabilization of identity-enforcing regulatory circuits, and sustained impairment of specialized function while cellular viability is preserved. In this Perspective, we propose a conceptual reframing in which immune systems are considered continuous regulators of cellular identity stability rather than solely as determinants of cell survival. The process becomes stabilized through epigenetic remodeling and generates persistent dysfunctional states that may be variably reversible depending on the duration and intensity of immune exposure. The proposed framework distinguishes immune-induced plasticity from epigenetically fixed identity failure. By repositioning immune instruction of cellular identity as one of the central mechanisms of disease pathogenesis, this framework opens new conceptual avenues. It further emphasizes therapeutic strategies focused on restoring tissue function through the reestablishment of differentiated states.
- 12 June 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1831391
Open AccessImmune signaling as a determinant of cellular identity and tissue function
Immunology has traditionally interpreted tissue pathology through models centered on immune-mediated cytotoxicity. In this prevailing model, functional decline is considered a downstream consequence of cell death and irreversible loss of cellular mass. Increasing evidence across metabolically active tissues challenges this paradigm by demonstrating that immune-derived signals exert potent regulatory effects on cellular identity that are independent of overt cytotoxicity. Cytokines, interferons, and inflammatory mediators directly engage transcriptional, epigenetic, and stress-response networks that sustain differentiated states. This engagement leads to suppression of lineage-defining gene programs, destabilization of identity-enforcing regulatory circuits, and sustained impairment of specialized function while cellular viability is preserved. In this Perspective, we propose a conceptual reframing in which immune systems are considered continuous regulators of cellular identity stability rather than solely as determinants of cell survival. The process becomes stabilized through epigenetic remodeling and generates persistent dysfunctional states that may be variably reversible depending on the duration and intensity of immune exposure. The proposed framework distinguishes immune-induced plasticity from epigenetically fixed identity failure. By repositioning immune instruction of cellular identity as one of the central mechanisms of disease pathogenesis, this framework opens new conceptual avenues. It further emphasizes therapeutic strategies focused on restoring tissue function through the reestablishment of differentiated states.
- Open Access
- 30 May 2026
- Published by MDPI AG in Antioxidants
- Vol. 15 (6) , 693
Polyphenol-Mediated Modulation of Oxidative Stress Pathways in Type 1 Diabetes: A Systematic Review
Oxidative stress is a central component of type 1 diabetes (T1D) pathophysiology, contributing to pancreatic β-cell vulnerability and the development of chronic complications. Current therapeutic strategies are primarily focused on glycemic control and do not directly address underlying redox imbalance. Dietary polyphenols, a structurally diverse class of plant-derived compounds, have been investigated for their antioxidant and cytoprotective properties, yet their role in T1D has not been systematically defined. This systematic review evaluates the effects of polyphenols on oxidative stress and glycemic parameters in preclinical models of T1D. Across studies, polyphenols were consistently associated with attenuation of oxidative stress, as evidenced by reductions in lipid peroxidation and reactive oxygen and nitrogen species, along with restoration of endogenous antioxidant defenses, including superoxide dismutase, catalase, and glutathione. These effects were frequently linked to modulation of redox-sensitive signaling pathways, particularly Nrf2-dependent mechanisms. In contrast, glycemic outcomes were heterogeneous and influenced by compound-specific and experimental factors. Modulation of oxidative stress markers was often observed independently of changes in glycemic parameters, suggesting a primary redox-mediated mode of action. These findings provide a mechanistic rationale for prioritizing oxidative-stress-focused endpoints in future translational studies and support the evaluation of polyphenols as adjunctive strategies targeting redox imbalance in T1D.
- 30 May 2026
- Published by MDPI AG in Antioxidants
- Vol. 15 (6) , 693
Open AccessPolyphenol-Mediated Modulation of Oxidative Stress Pathways in Type 1 Diabetes: A Systematic Review
Oxidative stress is a central component of type 1 diabetes (T1D) pathophysiology, contributing to pancreatic β-cell vulnerability and the development of chronic complications. Current therapeutic strategies are primarily focused on glycemic control and do not directly address underlying redox imbalance. Dietary polyphenols, a structurally diverse class of plant-derived compounds, have been investigated for their antioxidant and cytoprotective properties, yet their role in T1D has not been systematically defined. This systematic review evaluates the effects of polyphenols on oxidative stress and glycemic parameters in preclinical models of T1D. Across studies, polyphenols were consistently associated with attenuation of oxidative stress, as evidenced by reductions in lipid peroxidation and reactive oxygen and nitrogen species, along with restoration of endogenous antioxidant defenses, including superoxide dismutase, catalase, and glutathione. These effects were frequently linked to modulation of redox-sensitive signaling pathways, particularly Nrf2-dependent mechanisms. In contrast, glycemic outcomes were heterogeneous and influenced by compound-specific and experimental factors. Modulation of oxidative stress markers was often observed independently of changes in glycemic parameters, suggesting a primary redox-mediated mode of action. These findings provide a mechanistic rationale for prioritizing oxidative-stress-focused endpoints in future translational studies and support the evaluation of polyphenols as adjunctive strategies targeting redox imbalance in T1D.
- Open Access
- 27 May 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (11) , 4846
Structural Modulation and Binding of HLA-DQ8 by Cysteine-to-Serine Mutated Insulin Peptide: Insights from Molecular Dynamics Simulations
Type 1 diabetes (T1D) is driven by autoreactive CD4+ T-cell responses to pancreatic beta cell antigens presented by disease-associated human leucocyte antigen (HLA) class II molecules. However, the molecular mechanisms by which subtle antigenic modifications promote pathogenic immunity remain incompletely defined. Recent immunopeptidomic studies have identified a cysteine-to-serine substitution at position 19 of the insulin B chain, referred to as InsC19S, as a microenvironment-driven neoepitope that can be presented by HLA class II molecules, including HLA-DQ8, and is recognized by diabetogenic CD4+ T cells. In this study we explore potential structural and thermodynamic mechanisms that may contribute to the enhanced immunogenicity associated with this single-amino-acid modification. Using molecular dynamics simulations combined with coarse-grained free-energy-perturbation analyses, we compared HLA DQ8 complexes bound to wild-type (WT) insulin and InsC19S peptides. The InsC19S variant is predicted in simulations to exhibit enhanced binding stability, characterized by increased hydrogen bond occupancy, reduced peptide conformational mobility, and a more favorable binding free energy. In addition, the modified peptide is predicted to induce peptide-dependent conformational adjustments within the HLA-DQ8 peptide-binding groove, resulting in expansion of the conformational landscape and stabilization of distinct low-energy states that are not accessed by the WT complex. Principal component analysis and free-energy landscape mapping suggest that this mutation may promote altered collective motions within HLA DQ8 that are consistent with enhanced peptide major histocompatibility complex (MHC) persistence and optimized antigen presentation geometry. Together, these computational observations suggest a structural framework that may help explain the preferential presentation and pathogenic recognition of InsC19S reported in experimental studies. These findings provide a molecular-level framework that may help link microenvironment-driven insulin neoepitope formation to altered peptide–MHC stability and conformational dynamics in HLA-DQ8.
- 27 May 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (11) , 4846
Open AccessStructural Modulation and Binding of HLA-DQ8 by Cysteine-to-Serine Mutated Insulin Peptide: Insights from Molecular Dynamics Simulations
Type 1 diabetes (T1D) is driven by autoreactive CD4+ T-cell responses to pancreatic beta cell antigens presented by disease-associated human leucocyte antigen (HLA) class II molecules. However, the molecular mechanisms by which subtle antigenic modifications promote pathogenic immunity remain incompletely defined. Recent immunopeptidomic studies have identified a cysteine-to-serine substitution at position 19 of the insulin B chain, referred to as InsC19S, as a microenvironment-driven neoepitope that can be presented by HLA class II molecules, including HLA-DQ8, and is recognized by diabetogenic CD4+ T cells. In this study we explore potential structural and thermodynamic mechanisms that may contribute to the enhanced immunogenicity associated with this single-amino-acid modification. Using molecular dynamics simulations combined with coarse-grained free-energy-perturbation analyses, we compared HLA DQ8 complexes bound to wild-type (WT) insulin and InsC19S peptides. The InsC19S variant is predicted in simulations to exhibit enhanced binding stability, characterized by increased hydrogen bond occupancy, reduced peptide conformational mobility, and a more favorable binding free energy. In addition, the modified peptide is predicted to induce peptide-dependent conformational adjustments within the HLA-DQ8 peptide-binding groove, resulting in expansion of the conformational landscape and stabilization of distinct low-energy states that are not accessed by the WT complex. Principal component analysis and free-energy landscape mapping suggest that this mutation may promote altered collective motions within HLA DQ8 that are consistent with enhanced peptide major histocompatibility complex (MHC) persistence and optimized antigen presentation geometry. Together, these computational observations suggest a structural framework that may help explain the preferential presentation and pathogenic recognition of InsC19S reported in experimental studies. These findings provide a molecular-level framework that may help link microenvironment-driven insulin neoepitope formation to altered peptide–MHC stability and conformational dynamics in HLA-DQ8.
- Open Access
- 26 May 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (11) , 4789
The Gut–Pancreas Axis in Type 1 Diabetes: Emerging Insights into Microbiota and Immune Interactions
The gut microbiota is increasingly recognized as an important factor in the pathogenesis of type 1 diabetes (T1D), although its exact role in disease initiation and progression remains uncertain. Earlier interpretations considered alterations in intestinal microbial composition as secondary effects of immune dysregulation or metabolic disturbance. Recent longitudinal studies, however, suggest that specific microbial changes occur before the onset of islet autoimmunity, indicating a potential contributory role in the early phases of disease development. In this narrative review article, the gut–pancreas axis (GPA) is described as a dynamic and reciprocal system in which microbial, metabolic, and immune processes influence each other to shape β-cell outcomes. Evidence from human cohorts and experimental models links early life reductions in microbial diversity, impaired intestinal barrier function, and decreased production of short-chain fatty acids (SCFAs) to altered immune activation and β-cell damage. Microbiota transferred from individuals at risk for T1D has been shown to accelerate disease in animal models, supporting a possible causal relationship. Although experimental models support mechanistic links between microbiota alterations and autoimmune diabetes, current human evidence remains largely associative. Together, these findings suggest that microbial and immune networks interact in a feedback manner that can sustain immune tolerance or promote autoimmunity depending on environmental and host factors. Understanding T1D as a state of disrupted microbial and immune integration provides a basis for restoring gut–pancreas communication and preserving β-cell integrity.
- 26 May 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (11) , 4789
Open AccessThe Gut–Pancreas Axis in Type 1 Diabetes: Emerging Insights into Microbiota and Immune Interactions
The gut microbiota is increasingly recognized as an important factor in the pathogenesis of type 1 diabetes (T1D), although its exact role in disease initiation and progression remains uncertain. Earlier interpretations considered alterations in intestinal microbial composition as secondary effects of immune dysregulation or metabolic disturbance. Recent longitudinal studies, however, suggest that specific microbial changes occur before the onset of islet autoimmunity, indicating a potential contributory role in the early phases of disease development. In this narrative review article, the gut–pancreas axis (GPA) is described as a dynamic and reciprocal system in which microbial, metabolic, and immune processes influence each other to shape β-cell outcomes. Evidence from human cohorts and experimental models links early life reductions in microbial diversity, impaired intestinal barrier function, and decreased production of short-chain fatty acids (SCFAs) to altered immune activation and β-cell damage. Microbiota transferred from individuals at risk for T1D has been shown to accelerate disease in animal models, supporting a possible causal relationship. Although experimental models support mechanistic links between microbiota alterations and autoimmune diabetes, current human evidence remains largely associative. Together, these findings suggest that microbial and immune networks interact in a feedback manner that can sustain immune tolerance or promote autoimmunity depending on environmental and host factors. Understanding T1D as a state of disrupted microbial and immune integration provides a basis for restoring gut–pancreas communication and preserving β-cell integrity.
- Open Access
- 26 April 2026
- Published by MDPI AG in Antioxidants
- Vol. 15 (5) , 548
Oxidative-Stress-Associated Molecular Signatures in Immune-Mediated Diseases: A Systematic Review Integrating Machine Learning and Systems Biology Approaches
Oxidative stress is a key contributor to the pathogenesis of immune-mediated diseases through its effects on cellular metabolism, mitochondrial function, immune signaling pathways, and inflammatory tissue injury. Disruption of redox homeostasis promotes metabolic reprogramming and persistent activation of innate and adaptive immune responses, contributing to disease progression across multiple inflammatory and autoimmune disorders. Recent advances in high throughput molecular technologies have generated large scale multi-omics datasets that enable comprehensive investigation of redox-associated mechanisms at a systems level. Integration of these datasets with computational analytical approaches has facilitated the identification of multidimensional molecular signatures associated with disease development and progression. This systematic review evaluates studies applying computational frameworks to analyze redox-related molecular data in immune-mediated diseases including multiple sclerosis, systemic lupus erythematosus, lupus nephritis, rheumatoid arthritis, Sjögren’s syndrome, and inflammatory bowel disease. Across the reviewed studies, oxidative stress associated with molecular signatures were consistently linked to immune activation, mitochondrial metabolism, and inflammatory signaling pathways. Computational analyses also identified regulatory genes involved in antioxidant defense and metabolic regulation, as well as pathways associated with regulated cell death. These findings highlight the translational potential of computational redox analysis for biomarker discovery, disease stratification, and development of targeted therapeutic strategies aimed at restoring redox balance and improving clinical management of immune-mediated diseases.
- 26 April 2026
- Published by MDPI AG in Antioxidants
- Vol. 15 (5) , 548
Open AccessOxidative-Stress-Associated Molecular Signatures in Immune-Mediated Diseases: A Systematic Review Integrating Machine Learning and Systems Biology Approaches
Oxidative stress is a key contributor to the pathogenesis of immune-mediated diseases through its effects on cellular metabolism, mitochondrial function, immune signaling pathways, and inflammatory tissue injury. Disruption of redox homeostasis promotes metabolic reprogramming and persistent activation of innate and adaptive immune responses, contributing to disease progression across multiple inflammatory and autoimmune disorders. Recent advances in high throughput molecular technologies have generated large scale multi-omics datasets that enable comprehensive investigation of redox-associated mechanisms at a systems level. Integration of these datasets with computational analytical approaches has facilitated the identification of multidimensional molecular signatures associated with disease development and progression. This systematic review evaluates studies applying computational frameworks to analyze redox-related molecular data in immune-mediated diseases including multiple sclerosis, systemic lupus erythematosus, lupus nephritis, rheumatoid arthritis, Sjögren’s syndrome, and inflammatory bowel disease. Across the reviewed studies, oxidative stress associated with molecular signatures were consistently linked to immune activation, mitochondrial metabolism, and inflammatory signaling pathways. Computational analyses also identified regulatory genes involved in antioxidant defense and metabolic regulation, as well as pathways associated with regulated cell death. These findings highlight the translational potential of computational redox analysis for biomarker discovery, disease stratification, and development of targeted therapeutic strategies aimed at restoring redox balance and improving clinical management of immune-mediated diseases.